Management of infections in critically ill returning travellers in the intensive care unit-I: considerations on infection control and transmission of resistance.
Identifieur interne : 001140 ( PubMed/Corpus ); précédent : 001139; suivant : 001141Management of infections in critically ill returning travellers in the intensive care unit-I: considerations on infection control and transmission of resistance.
Auteurs : Hakan Leblebicioglu ; Alfonso J. Rodriguez-Morales ; Gian Maria Rossolini ; Rogelio L Pez-Vélez ; Jean-Ralph Zahar ; Jordi RelloSource :
- International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [ 1878-3511 ] ; 2016.
English descriptors
- KwdEn :
- MESH :
- epidemiology : Critical Illness.
- methods : Infection Control.
- therapy : Infections.
- transmission : Infections.
- Disease Outbreaks, Humans, Intensive Care Units, Travel.
Abstract
Depending on their destinations and activities, international travellers are at a significant risk of contracting both communicable and non-communicable diseases. On return to their home countries, such travellers may require intensive care. The emergence of severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), and more recently Ebola haemorrhagic fever, has highlighted the risks. Other well-known communicable pathogens such as methicillin-resistant Staphylococcus aureus and carbapenemase-producing Enterobacteriaceae have been described previously. However, malaria remains by far the most important cause of death. The issues related to imported antibiotic resistance and protection from highly contagious diseases are reviewed here. Surveillance strategies based on epidemiological data (country visited, duration of travel, and time elapsed since return) and clinical syndromes, together with systematic search policies, are usually mandatory to limit the risk of an outbreak. Single-bed hospital rooms and isolation according to symptoms should be the rule while awaiting laboratory test results. Because person-to-person contact is the main route of transmission, healthcare workers should implement specific prevention strategies.
DOI: 10.1016/j.ijid.2016.04.019
PubMed: 27134158
Links to Exploration step
pubmed:27134158Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Management of infections in critically ill returning travellers in the intensive care unit-I: considerations on infection control and transmission of resistance.</title><author><name sortKey="Leblebicioglu, Hakan" sort="Leblebicioglu, Hakan" uniqKey="Leblebicioglu H" first="Hakan" last="Leblebicioglu">Hakan Leblebicioglu</name><affiliation><nlm:affiliation>Department of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University Medical School, Samsun, Turkey.</nlm:affiliation></affiliation></author><author><name sortKey="Rodriguez Morales, Alfonso J" sort="Rodriguez Morales, Alfonso J" uniqKey="Rodriguez Morales A" first="Alfonso J" last="Rodriguez-Morales">Alfonso J. Rodriguez-Morales</name><affiliation><nlm:affiliation>Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, Colombia.</nlm:affiliation></affiliation></author><author><name sortKey="Rossolini, Gian Maria" sort="Rossolini, Gian Maria" uniqKey="Rossolini G" first="Gian Maria" last="Rossolini">Gian Maria Rossolini</name><affiliation><nlm:affiliation>Department of Medical Biotechnologies, University of Siena, Siena, Italy; Department of Experimental and Clinical Medicine, University of Florence, and Clinical Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="L Pez Velez, Rogelio" sort="L Pez Velez, Rogelio" uniqKey="L Pez Velez R" first="Rogelio" last="L Pez-Vélez">Rogelio L Pez-Vélez</name><affiliation><nlm:affiliation>National Referral Unit for Tropical Diseases, Infectious Diseases Department, Ramón y Cajal University Hospital, Madrid, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Zahar, Jean Ralph" sort="Zahar, Jean Ralph" uniqKey="Zahar J" first="Jean-Ralph" last="Zahar">Jean-Ralph Zahar</name><affiliation><nlm:affiliation>Infection Control Unit, Université d'Angers, Centre Hospitalier Universitaire d'Angers, Angers, France.</nlm:affiliation></affiliation></author><author><name sortKey="Rello, Jordi" sort="Rello, Jordi" uniqKey="Rello J" first="Jordi" last="Rello">Jordi Rello</name><affiliation><nlm:affiliation>CIBERES, Vall Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: jrello@crips.es.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27134158</idno><idno type="pmid">27134158</idno><idno type="doi">10.1016/j.ijid.2016.04.019</idno><idno type="wicri:Area/PubMed/Corpus">001140</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001140</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Management of infections in critically ill returning travellers in the intensive care unit-I: considerations on infection control and transmission of resistance.</title><author><name sortKey="Leblebicioglu, Hakan" sort="Leblebicioglu, Hakan" uniqKey="Leblebicioglu H" first="Hakan" last="Leblebicioglu">Hakan Leblebicioglu</name><affiliation><nlm:affiliation>Department of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University Medical School, Samsun, Turkey.</nlm:affiliation></affiliation></author><author><name sortKey="Rodriguez Morales, Alfonso J" sort="Rodriguez Morales, Alfonso J" uniqKey="Rodriguez Morales A" first="Alfonso J" last="Rodriguez-Morales">Alfonso J. Rodriguez-Morales</name><affiliation><nlm:affiliation>Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, Colombia.</nlm:affiliation></affiliation></author><author><name sortKey="Rossolini, Gian Maria" sort="Rossolini, Gian Maria" uniqKey="Rossolini G" first="Gian Maria" last="Rossolini">Gian Maria Rossolini</name><affiliation><nlm:affiliation>Department of Medical Biotechnologies, University of Siena, Siena, Italy; Department of Experimental and Clinical Medicine, University of Florence, and Clinical Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="L Pez Velez, Rogelio" sort="L Pez Velez, Rogelio" uniqKey="L Pez Velez R" first="Rogelio" last="L Pez-Vélez">Rogelio L Pez-Vélez</name><affiliation><nlm:affiliation>National Referral Unit for Tropical Diseases, Infectious Diseases Department, Ramón y Cajal University Hospital, Madrid, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Zahar, Jean Ralph" sort="Zahar, Jean Ralph" uniqKey="Zahar J" first="Jean-Ralph" last="Zahar">Jean-Ralph Zahar</name><affiliation><nlm:affiliation>Infection Control Unit, Université d'Angers, Centre Hospitalier Universitaire d'Angers, Angers, France.</nlm:affiliation></affiliation></author><author><name sortKey="Rello, Jordi" sort="Rello, Jordi" uniqKey="Rello J" first="Jordi" last="Rello">Jordi Rello</name><affiliation><nlm:affiliation>CIBERES, Vall Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: jrello@crips.es.</nlm:affiliation></affiliation></author></analytic><series><title level="j">International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</title><idno type="eISSN">1878-3511</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Critical Illness (epidemiology)</term><term>Disease Outbreaks</term><term>Humans</term><term>Infection Control (methods)</term><term>Infections (therapy)</term><term>Infections (transmission)</term><term>Intensive Care Units</term><term>Travel</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Critical Illness</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Infection Control</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Infections</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Infections</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Disease Outbreaks</term><term>Humans</term><term>Intensive Care Units</term><term>Travel</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Depending on their destinations and activities, international travellers are at a significant risk of contracting both communicable and non-communicable diseases. On return to their home countries, such travellers may require intensive care. The emergence of severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), and more recently Ebola haemorrhagic fever, has highlighted the risks. Other well-known communicable pathogens such as methicillin-resistant Staphylococcus aureus and carbapenemase-producing Enterobacteriaceae have been described previously. However, malaria remains by far the most important cause of death. The issues related to imported antibiotic resistance and protection from highly contagious diseases are reviewed here. Surveillance strategies based on epidemiological data (country visited, duration of travel, and time elapsed since return) and clinical syndromes, together with systematic search policies, are usually mandatory to limit the risk of an outbreak. Single-bed hospital rooms and isolation according to symptoms should be the rule while awaiting laboratory test results. Because person-to-person contact is the main route of transmission, healthcare workers should implement specific prevention strategies. </div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">27134158</PMID><DateCompleted><Year>2017</Year><Month>02</Month><Day>02</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-3511</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><PubDate><Year>2016</Year><Month>Jul</Month></PubDate></JournalIssue><Title>International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</Title><ISOAbbreviation>Int. J. Infect. Dis.</ISOAbbreviation></Journal><ArticleTitle>Management of infections in critically ill returning travellers in the intensive care unit-I: considerations on infection control and transmission of resistance.</ArticleTitle><Pagination><MedlinePgn>113-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijid.2016.04.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1201-9712(16)31036-0</ELocationID><Abstract><AbstractText>Depending on their destinations and activities, international travellers are at a significant risk of contracting both communicable and non-communicable diseases. On return to their home countries, such travellers may require intensive care. The emergence of severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), and more recently Ebola haemorrhagic fever, has highlighted the risks. Other well-known communicable pathogens such as methicillin-resistant Staphylococcus aureus and carbapenemase-producing Enterobacteriaceae have been described previously. However, malaria remains by far the most important cause of death. The issues related to imported antibiotic resistance and protection from highly contagious diseases are reviewed here. Surveillance strategies based on epidemiological data (country visited, duration of travel, and time elapsed since return) and clinical syndromes, together with systematic search policies, are usually mandatory to limit the risk of an outbreak. Single-bed hospital rooms and isolation according to symptoms should be the rule while awaiting laboratory test results. Because person-to-person contact is the main route of transmission, healthcare workers should implement specific prevention strategies. </AbstractText><CopyrightInformation>Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leblebicioglu</LastName><ForeName>Hakan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University Medical School, Samsun, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Morales</LastName><ForeName>Alfonso J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossolini</LastName><ForeName>Gian Maria</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Medical Biotechnologies, University of Siena, Siena, Italy; Department of Experimental and Clinical Medicine, University of Florence, and Clinical Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>López-Vélez</LastName><ForeName>Rogelio</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>National Referral Unit for Tropical Diseases, Infectious Diseases Department, Ramón y Cajal University Hospital, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zahar</LastName><ForeName>Jean-Ralph</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Infection Control Unit, Université d'Angers, Centre Hospitalier Universitaire d'Angers, Angers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rello</LastName><ForeName>Jordi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>CIBERES, Vall Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: jrello@crips.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>ESGCIP and ESGITM</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Int J Infect Dis</MedlineTA><NlmUniqueID>9610933</NlmUniqueID><ISSNLinking>1201-9712</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="Y">Critical Illness</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017053" MajorTopicYN="N">Infection Control</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007239" MajorTopicYN="N">Infections</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014195" MajorTopicYN="Y">Travel</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ICU</Keyword><Keyword MajorTopicYN="N">Infection control</Keyword><Keyword MajorTopicYN="N">Migrant</Keyword><Keyword MajorTopicYN="N">Resistance</Keyword><Keyword MajorTopicYN="N">Traveller</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>01</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>04</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>04</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27134158</ArticleId><ArticleId IdType="pii">S1201-9712(16)31036-0</ArticleId><ArticleId IdType="doi">10.1016/j.ijid.2016.04.019</ArticleId><ArticleId IdType="pmc">PMC7110831</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lancet Infect Dis. 2013 Sep;13(9):785-96</Citation><ArticleIdList><ArticleId IdType="pubmed">23969216</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet Infect Dis. 2009 May;9(5):301-11</Citation><ArticleIdList><ArticleId IdType="pubmed">19393960</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Intern Med. 2015 May;277(5):501-12</Citation><ArticleIdList><ArticleId IdType="pubmed">25556628</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Curr Opin Pharmacol. 2014 Oct;18:56-60</Citation><ArticleIdList><ArticleId IdType="pubmed">25254623</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Travel Med. 2014 Jul-Aug;21(4):272-81</Citation><ArticleIdList><ArticleId IdType="pubmed">24894491</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Hosp Infect. 2015 Jul;90(3):186-95</Citation><ArticleIdList><ArticleId IdType="pubmed">25986165</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Microbiol Infect. 2004 Nov;10(11):972-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15521999</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Antimicrob Chemother. 2013 Sep;68(9):2144-53</Citation><ArticleIdList><ArticleId IdType="pubmed">23674762</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Microbiol Infect. 2015 Jun;21(6):567.e1-10</Citation><ArticleIdList><ArticleId IdType="pubmed">25753191</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Infect Dis. 2013 May;56(9):1310-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23334810</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>BMC Infect Dis. 2014 Oct 01;14:528</Citation><ArticleIdList><ArticleId IdType="pubmed">25270732</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet Infect Dis. 2006 Jun;6(6):317-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16728314</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Int J Antimicrob Agents. 2012 Apr;39(4):273-82</Citation><ArticleIdList><ArticleId IdType="pubmed">22230333</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Vector Borne Zoonotic Dis. 2012 Sep;12(9):805-11</Citation><ArticleIdList><ArticleId IdType="pubmed">22607078</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Int J Infect Dis. 2016 Jul;48:120-2</Citation><ArticleIdList><ArticleId IdType="pubmed">27117201</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Med J Malaysia. 2012 Dec;67(6):636-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23770966</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Curr Opin Infect Dis. 2014 Oct;27(5):411-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25033169</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Ther. 2012 Jan;34(1):124-37</Citation><ArticleIdList><ArticleId IdType="pubmed">22154196</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Am J Infect Control. 2007 Dec;35(10 Suppl 2):S65-164</Citation><ArticleIdList><ArticleId IdType="pubmed">18068815</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Antimicrob Chemother. 2012 Sep;67(9):2090-100</Citation><ArticleIdList><ArticleId IdType="pubmed">22678728</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Am J Trop Med Hyg. 2013 Feb;88(2):397-404</Citation><ArticleIdList><ArticleId IdType="pubmed">23324216</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Microb Drug Resist. 2015 Jun;21(3):307-14</Citation><ArticleIdList><ArticleId IdType="pubmed">25569024</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Med Clin North Am. 2013 Nov;31(4):927-44</Citation><ArticleIdList><ArticleId IdType="pubmed">24176472</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Assoc Physicians India. 2006 Apr;54:291-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16944613</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Clin Microbiol. 2006 Nov;44(11):4189-92</Citation><ArticleIdList><ArticleId IdType="pubmed">16957031</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2015 Feb 26;372(9):846-54</Citation><ArticleIdList><ArticleId IdType="pubmed">25714162</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Am J Trop Med Hyg. 2010 Jun;82(6):1121-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20519611</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001140 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001140 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:27134158
|texte= Management of infections in critically ill returning travellers in the intensive care unit-I: considerations on infection control and transmission of resistance.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:27134158" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |